FTC Aims To Limit Cephalon Evidence In Pay-For-Delay Trial
The Federal Trade Commission launched a bid Friday to keep Cephalon Inc. from introducing certain evidence in a pay-for-delay suit in Pennsylvania federal court over a blockbuster narcolepsy drug, the agency's...To view the full article, register now.
Already a subscriber? Click here to view full article